110 related articles for article (PubMed ID: 3991364)
1. Hypermotility induced by vasoactive intestinal peptide in the rat: its reciprocal action to cholecystokinin octapeptide.
Itoh S; Katsuura G; Yoshikawa K
Peptides; 1985; 6(1):53-7. PubMed ID: 3991364
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholecystokinin and vasoactive intestinal peptide on locomotion and rearing in neofrontal decorticated rats.
Katsuura G; Itoh S
Prog Clin Biol Res; 1985; 192():147-50. PubMed ID: 4080707
[TBL] [Abstract][Full Text] [Related]
3. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
Katsuura G; Itoh S; Rehfeld JF
Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraventricular administration of vasoactive intestinal polypeptide on body temperature in the rat.
Itoh S; Hirota R
Jpn J Physiol; 1982; 32(4):677-81. PubMed ID: 6129338
[TBL] [Abstract][Full Text] [Related]
5. Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
Itoh S; Katsuura G
Eur J Pharmacol; 1981 Nov; 75(4):313-6. PubMed ID: 6274669
[TBL] [Abstract][Full Text] [Related]
6. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
Katsuura G; Itoh S
Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
[TBL] [Abstract][Full Text] [Related]
7. Interaction of cholecystokinin with vasoactive intestinal peptide in body shaking response to ice-water immersion in rats.
Katsuura G; Yoshikawa K; Itoh S
Neurosci Lett; 1983 Oct; 40(3):299-302. PubMed ID: 6646503
[TBL] [Abstract][Full Text] [Related]
8. Effect of cholecystokinin octapeptide and vasoactive intestinal polypeptide on adrenocortical secretion in the rat.
Itoh S; Hirota R; Katsuura G
Jpn J Physiol; 1982; 32(4):553-60. PubMed ID: 6294390
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
Tanimoto K; Tamminga CA; Chase TN; Nilaver G
Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of cholecystokinin-induced exocrine secretion by either electrical stimulation of the vagus nerve or exogenous VIP administration in the guinea pig pancreas.
Matsumoto T; Kanno T
Peptides; 1984; 5(2):285-9. PubMed ID: 6089131
[TBL] [Abstract][Full Text] [Related]
11. Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction.
Strah KM; Melendez RL; Pappas TN; Debas HT
Surgery; 1986 Apr; 99(4):469-73. PubMed ID: 3952671
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system].
Zhang J; Zou S; Qiu F
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):48-51. PubMed ID: 10374510
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas.
Sandberg E; Ahrén B; Tendler D; Efendic S
Acta Endocrinol (Copenh); 1988 Apr; 117(4):545-51. PubMed ID: 3291528
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacological properties of V-9-M, a putative neuropeptide derived from procholecystokinin, in the rat.
Takashima A; Itoh S
Can J Physiol Pharmacol; 1989 Mar; 67(3):223-7. PubMed ID: 2501013
[TBL] [Abstract][Full Text] [Related]
16. Supramaximal CCK and CCh concentrations abolish VIP potentiation by inhibiting adenylyl cyclase activity.
Akiyama T; Hirohata Y; Okabayashi Y; Imoto I; Otsuki M
Am J Physiol; 1998 Nov; 275(5):G1202-8. PubMed ID: 9815052
[TBL] [Abstract][Full Text] [Related]
17. Effect of vasoactive intestinal peptide, somatostatin, neurotensin, cholecystokinin octapeptide, and secretin on intestinal absorption of amino acid in rat.
Chen YF; Feng ZT; Wen SH; Lu GJ
Dig Dis Sci; 1987 Oct; 32(10):1125-9. PubMed ID: 2888609
[TBL] [Abstract][Full Text] [Related]
18. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
van Ree JM; Igarashi J; Király I
NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
[TBL] [Abstract][Full Text] [Related]
19. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
Hsiao S; Katsuura G; Itoh S
Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
[TBL] [Abstract][Full Text] [Related]
20. Changes in brown adipose tissue metabolism following intraventricular vasoactive intestinal peptide and other gastrointestinal peptides in rats.
Shido O; Yoneda Y; Nagasaka T
Jpn J Physiol; 1989; 39(3):359-69. PubMed ID: 2796018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
